Synapse assembly and neurodevelopmental disorders

Neuropsychopharmacology

Volumn 40, Issue 1, 2015, Pages 4-15

  Washbourne, Philip ^a  

^a UNIVERSITY OF OREGON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NERVE PROTEIN;

CHILD; DEVELOPMENTAL DISORDER; GENETICS; HUMAN; METABOLISM; NERVE CELL PLASTICITY; NERVOUS SYSTEM DEVELOPMENT; PHYSIOLOGY; SYNAPSE;

CHILD; DEVELOPMENTAL DISABILITIES; HUMANS; NERVE TISSUE PROTEINS; NEUROGENESIS; NEURONAL PLASTICITY; SYNAPSES;

EID: 84926656475     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2014.163     Document Type: Review

References (152)

1. Ahmari SE, Buchanan J, Smith SJ (2000). Assembly of presynaptic active zones from cytoplasmic transport packets. Nat Neurosci 3: 445-451.
2. Aldinger KA, Plummer JT, Qiu S, Levitt P (2011). SnapShot: genetics of autism. Neuron 72: 418-418 e411.
3. Allen NJ, Bennett ML, Foo LC, Wang GX, Chakraborty C, Smith SJ et al (2012). Astrocyte glypicans 4 and 6 promote formation of excitatory synapses via GluA1 AMPA receptors. Nature 486: 410-414.
4. Auerbach BD, Osterweil EK, Bear MF (2011). Mutations causing syndromic autism define an axis of synaptic pathophysiology. Nature 480: 63-68.
5. Awadalla P, Gauthier J, Myers RA, Casals F, Hamdan FF, Griffing AR et al (2010). Direct measure of the de novo mutation rate in autism and schizophrenia cohorts. Am J Hum Genet 87: 316-324.
6. Ballas N, Lioy DT, Grunseich C, Mandel G (2009). Non-cell autonomous influence of MeCP2-deficient glia on neuronal dendritic morphology. Nat Neurosci 12: 311-317.
7. Banker GA (1980). Trophic interactions between astroglial cells and hippocampal neurons in culture. Science 209: 809-810.
8. Barker AJ, Koch SM, Reed J, Barres BA, Ullian EM (2008). Developmental control of synaptic receptivity. J Neurosci 28: 8150-8160.
9. Barrow SL, Constable JR, Clark E, El-Sabeawy F, McAllister AK, Washbourne P (2009). Neuroligin1: a cell adhesion molecule that recruits PSD-95 and NMDA receptors by distinct mechanisms during synaptogenesis. Neural Dev 4: 17.
10. Baudouin SJ, Gaudias J, Gerharz S, Hatstatt L, Zhou K, Punnakkal P et al (2012). Shared synaptic pathophysiology in syndromic and nonsyndromic rodent models of autism. Science 338: 128-132.
11. Berkel S, Marshall CR, Weiss B, Howe J, Roeth R, Moog U et al (2010). Mutations in the SHANK2 synaptic scaffolding gene in autism spectrum disorder and mental retardation. Nat Genet 42: 489-491.
12. Biederer T (2006). Bioinformatic characterization of the SynCAM family of immunoglobulin-like domain-containing adhesion molecules. Genomics 87: 139-150.
13. Biederer T, Sara Y, Mozhayeva M, Atasoy D, Liu X, Kavalali ET et al (2002). SynCAM, a synaptic adhesion molecule that drives synapse assembly. Science 297: 1525-1531.
14. Biederer T, Scheiffele P (2007). Mixed-culture assays for analyzing neuronal synapse formation. Nat Protoc 2: 670-676.
15. Biederman J, Mick E, Faraone SV, Spencer T, Wilens TE, Wozniak J (2000). Pediatric mania: a developmental subtype of bipolar disorder? Biol Psychiatry 48: 458-466.
16. Blasi G, Napolitano F, Ursini G, Di Giorgio A, Caforio G, Taurisano P et al (2013). Association of GSK-3beta genetic variation with GSK-3beta expression, prefrontal cortical thickness, prefrontal physiology, and schizophrenia. Am J Psychiatry 170: 868-876.
17. Bourgeron T (2009). A synaptic trek to autism. Curr Opin Neurobiol 19: 231-234.
18. Boyes J, Bird A (1991). DNA methylation inhibits transcription indirectly via a methyl-CpG binding protein. Cell 64: 1123-1134.
19. Bozdagi O, Sakurai T, Papapetrou D, Wang X, Dickstein DL, Takahashi N et al (2010). Haploinsufficiency of the autism-associated Shank3 gene leads to deficits in synaptic function, social interaction, and social communication. Mol Autism 1: 15.
20. Brose N, O'Connor V, Skehel P (2010). Synaptopathy: dysfunction of synaptic function? Biochem Soc Trans 38: 443-444.
21. Bukalo O, Dityatev A (2012). Synaptic cell adhesion molecules. Adv Exp Med Biol 970: 97-128.
22. Bury LA, Sabo SL (2011). Coordinated trafficking of synaptic vesicle and active zone proteins before synapse formation. Neural Dev 6: 24.
23. Calboli FC, Tozzi F, Galwey NW, Antoniades A, Mooser V, Preisig M et al (2010). A genome-wide association study of neuroticism in a population-based sample. PLoS One 5: e11504.
24. Chadman KK, Gong S, Scattoni ML, Boltuck SE, Gandhy SU, Heintz N et al (2008). Minimal aberrant behavioral phenotypes of neuroligin-3 R451C knockin mice. Autism Res 1: 147-158.
25. Cheadle L, Biederer T (2012). The novel synaptogenic protein Farp1 links postsynaptic cytoskeletal dynamics and transsynaptic organization. J Cell Biol 199: 985-1001.
26. Cheung ZH, Ip NY (2007). The roles of cyclin-dependent kinase 5 in dendrite and synapse development. Biotechnol J 2: 949-957.
27. Christopherson KS, Ullian EM, Stokes CC, Mullowney CE, Hell JW, Agah A et al (2005). Thrombospondins are astrocyte-secreted proteins that promote CNS synaptogenesis. Cell 120: 421-433.
28. Clarke LE, Barres BA (2013). Emerging roles of astrocytes in neural circuit development. Nat Rev Neurosci 14: 311-321.
29. Corvin AP (2010). Neuronal cell adhesion genes: key players in risk for schizophrenia, bipolar disorder and other neurodevelopmental brain disorders? Cell Adh Migr 4: 511-514.
30. Craven SE, Bredt DS (1998). PDZ proteins organize synaptic signaling pathways. Cell 93: 495-498.
31. Dahlhaus R, Hines RM, Eadie BD, Kannangara TS, Hines DJ, Brown CE et al (2010). Overexpression of the cell adhesion protein neuroligin-1 induces learning deficits and impairs synaptic plasticity by altering the ratio of excitation to inhibition in the hippocampus. Hippocampus 20: 305-322.
32. de Wit J, Sylwestrak E, O'Sullivan ML, Otto S, Tiglio K, Savas JN et al (2009). LRRTM2 interacts with Neurexin1 and regulates excitatory synapse formation. Neuron 64: 799-806.
33. Dean C, Scholl FG, Choih J, DeMaria S, Berger J, Isacoff E et al (2003). Neurexin mediates the assembly of presynaptic terminals. Nat Neurosci 6: 708-716.
34. Della Ragione F, Filosa S, Scalabri F, D'Esposito M (2012). MeCP2 as a genomewide modulator: the renewal of an old story. Front Genet 3: 181.
35. Dhariwala FA, Rajadhyaksha MS (2008). An unusual member of the Cdk family: Cdk5. Cell Mol Neurobiol 28: 351-369.
36. Dimitratos SD, Stathakis DG, Nelson CA, Woods DF, Bryant PJ (1998). The location of human CASK at Xp11.4 identifies this gene as a candidate for X-linked optic atrophy. Genomics 51: 308-309.
37. Easley-Neal C, Fierro J Jr., Buchanan J, Washbourne P (2013). Late recruitment of synapsin to nascent synapses is regulated by Cdk5. Cell Rep 3: 1199-1212.
38. Ellegood J, Lerch JP, Henkelman RM (2011). Brain abnormalities in a Neuroligin3 R451C knockin mouse model associated with autism. Autism Res 4: 368-376.
39. Engmann O, Hortobagyi T, Pidsley R, Troakes C, Bernstein HG, Kreutz MR et al (2011). Schizophrenia is associated with dysregulation of a Cdk5 activator that regulates synaptic protein expression and cognition. Brain 134: 2408-2421.
40. Etherton MR, Blaiss CA, Powell CM, Sudhof TC (2009). Mouse neurexin-1alpha deletion causes correlated electrophysiological and behavioral changes consistent with cognitive impairments. Proc Natl Acad Sci USA 106: 17998-18003.
41. Etherton MR, Tabuchi K, Sharma M, Ko J, Sudhof TC (2011). An autism-associated point mutation in the neuroligin cytoplasmic tail selectively impairs AMPA receptor-mediated synaptic transmission in hippocampus. EMBO J 30: 2908-2919.
42. Ey E, Yang M, Katz AM, Woldeyohannes L, Silverman JL, Leblond CS et al (2012). Absence of deficits in social behaviors and ultrasonic vocalizations in later generations of mice lacking neuroligin4. Genes Brain Behav 11: 928-941.
43. Froyen G, Van Esch H, Bauters M, Hollanders K, Frints SG, Vermeesch JR et al (2007). Detection of genomic copy number changes in patients with idiopathic mental retardation by high-resolution X-array-CGH: important role for increased gene dosage of XLMR genes. Hum Mutat 28: 1034-1042.
44. Fu Z, Washbourne P, Ortinski P, Vicini S (2003). Functional excitatory synapses in HEK293 cells expressing neuroligin and glutamate receptors. J Neurophysiol 90: 3950-3957.
45. Gipson TT, Johnston MV (2012). Plasticity and mTOR: towards restoration of impaired synaptic plasticity in mTOR-related neurogenetic disorders. Neural Plast 2012: 486402.
46. Glessner JT, Wang K, Cai G, Korvatska O, Kim CE, Wood S et al (2009). Autism genome-wide copy number variation reveals ubiquitin and neuronal genes. Nature 459: 569-573.
47. Goedert M, Klug A, Crowther RA (2006). Tau protein, the paired helical filament and Alzheimer's disease. J Alzheimers Dis 9: 195-207.
48. Gokce O, Sudhof TC (2013). Membrane-tethered monomeric neurexin LNS-domain triggers synapse formation. J Neurosci 33: 14617-14628.
49. Goldstein AY, Wang X, Schwarz TL (2008). Axonal transport and the delivery of presynaptic components. Curr Opin Neurobiol 18: 495-503.
50. Goold RG, Owen R, Gordon-Weeks PR (1999). Glycogen synthase kinase 3beta phosphorylation of microtubule-associated protein 1B regulates the stability of microtubules in growth cones. J Cell Sci 112(Pt 19): 3373-3384.
51. Grabrucker AM, Schmeisser MJ, Schoen M, Boeckers TM (2011). Postsynaptic ProSAP/Shank scaffolds in the cross-hair of synaptopathies. Trends Cell Biol 21: 594-603.
52. Grayton HM, Missler M, Collier DA, Fernandes C (2013). Altered social behaviours in neurexin 1alpha knockout mice resemble core symptoms in neurodevelopmental disorders. PLoS One 8: e67114.
53. Greenough WT, Klintsova AY, Irwin SA, Galvez R, Bates KE, Weiler IJ (2001). Synaptic regulation of protein synthesis and the fragile X protein. Proc Natl Acad Sci USA 98: 7101-7106.
54. Groc L, Bard L, Choquet D (2009). Surface trafficking of N-methyl-Daspartate receptors: physiological and pathological perspectives. Neuroscience 158: 4-18.
55. Guilmatre A, Huguet G, Delorme R, Bourgeron T (2014). The emerging role of SHANK genes in neuropsychiatric disorders. Dev Neurobiol 74: 113-122.
56. Guy J, Gan J, Selfridge J, Cobb S, Bird A (2007). Reversal of neurological defects in a mouse model of Rett syndrome. Science 315: 1143-1147.
57. Hackett A, Tarpey PS, Licata A, Cox J, Whibley A, Boyle J et al (2009). CASK mutations are frequent in males and cause X-linked nystagmus and variable XLMR phenotypes. Eur J Hum Genet 18: 544-552.
58. Hata Y, Butz S, Sudhof TC (1996). CASK: a novel dlg/PSD95 homolog with an N-terminal calmodulin-dependent protein kinase domain identified by interaction with neurexins. J Neurosci 16: 2488-2494.
59. Hayashi S, Mizuno S, Migita O, Okuyama T, Makita Y, Hata A et al (2008). The CASK gene harbored in a deletion detected by array-CGH as a potential candidate for a gene causative of X-linked dominant mental retardation. Am J Med Genet A 146A: 2145-2151.
60. Hirai H, Pang Z, Bao D, Miyazaki T, Li L, Miura E et al (2005). Cbln1 is essential for synaptic integrity and plasticity in the cerebellum. Nat Neurosci 8: 1534-1541.
61. Hirokawa N, Niwa S, Tanaka Y (2010). Molecular motors in neurons: transport mechanisms and roles in brain function, development, and disease. Neuron 68: 610-638.
62. Hoy JL, Haeger PA, Constable JR, Arias RJ, McCallum R, Kyweriga M et al (2013). Neuroligin1 drives synaptic and behavioral maturation through intracellular interactions. J Neurosci 33: 9364-9384.
63. Hsueh YP (2006). The role of the MAGUK protein CASK in neural development and synaptic function. Curr Med Chem 13: 1915-1927.
64. Hsueh YP, Wang TF, Yang FC, Sheng M (2000). Nuclear translocation and transcription regulation by the membrane-associated guanylate kinase CASK/ LIN-2. Nature 404: 298-302.
65. Huber KM, Gallagher SM, Warren ST, Bear MF (2002). Altered synaptic plasticity in a mouse model of fragile X mental retardation. Proc Natl Acad Sci USA 99: 7746-7750.
66. Huttenlocher PR, Dabholkar AS (1997). Regional differences in synaptogenesis in human cerebral cortex. J Comp Neurol 387: 167-178.
67. Irwin SA, Patel B, Idupulapati M, Harris JB, Crisostomo RA, Larsen BP et al (2001). Abnormal dendritic spine characteristics in the temporal and visual cortices of patients with fragile-X syndrome: a quantitative examination. Am J Med Genet 98: 161-167.
68. Jacobs S, Doering LC (2010). Astrocytes prevent abnormal neuronal development in the fragile X mouse. J Neurosci 30: 4508-4514.
69. Jamain S, Quach H, Betancur C, Rastam M, Colineaux C, Gillberg IC et al (2003). Mutations of the X-linked genes encoding neuroligins NLGN3 and NLGN4 are associated with autism. Nat Genet 34: 27-29.
70. Jamain S, Radyushkin K, Hammerschmidt K, Granon S, Boretius S, Varoqueaux F et al (2008). Reduced social interaction and ultrasonic communication in a mouse model of monogenic heritable autism. Proc Natl Acad Sci USA 105: 1710-1715.
71. Jaramillo TC, Liu S, Pettersen A, Birnbaum SG, Powell CM (2014). Autism-related neuroligin-3 mutation alters social behavior and spatial learning. Autism Res 7: 264-272.
72. Kaech S, Banker G (2006). Culturing hippocampal neurons. Nat Protoc 1: 2406-2415.
73. Kamal A, Almenar-Queralt A, LeBlanc JF, Roberts EA, Goldstein LS (2001). Kinesinmediated axonal transport of a membrane compartment containing betasecretase and presenilin-1 requires APP. Nature 414: 643-648.
74. Kayadjanian N, Lee HS, Pina-Crespo J, Heinemann SF (2007). Localization of glutamate receptors to distal dendrites depends on subunit composition and the kinesin motor protein KIF17. Mol Cell Neurosci 34: 219-230.
75. Ko J, Fuccillo MV, Malenka RC, Sudhof TC (2009). LRRTM2 functions as a Neurexin ligand in promoting excitatory synapse formation. Neuron 64: 791-798.
76. Kohli BM, Pflieger D, Mueller LN, Carbonetti G, Aebersold R, Nitsch RM et al (2012). Interactome of the amyloid precursor protein APP in brain reveals a protein network involved in synaptic vesicle turnover and a close association with Synaptotagmin-1. J Proteome Res 11: 4075-4090.
77. Koolen DA, Vissers LE, Pfundt R, de Leeuw N, Knight SJ, Regan R et al (2006). A new chromosome 17q21.31 microdeletion syndrome associated with a common inversion polymorphism. Nat Genet 38: 999-1001.
78. Kumar A, Swanwick CC, Johnson N, Menashe I, Basu SN, Bales ME et al (2011). A brain region-specific predictive gene map for autism derived by profiling a reference gene set. PLoS One 6: e28431.
79. Kwon HB, Kozorovitskiy Y, Oh WJ, Peixoto RT, Akhtar N, Saulnier JL et al (2012). Neuroligin-1-dependent competition regulates cortical synaptogenesis and synapse number. Nat Neurosci 15: 1667-1674.
80. Laarakker MC, Reinders NR, Bruining H, Ophoff RA, Kas MJ (2012). Sex-dependent novelty response in neurexin-1alpha mutant mice. PLoS One 7: e31503.
81. Laumonnier F, Bonnet-Brilhault F, Gomot M, Blanc R, David A, Moizard MP et al (2004). X-linked mental retardation and autism are associated with a mutation in the NLGN4 gene, a member of the neuroligin family. Am J Hum Genet 74: 552-557.
82. Lazarov O, Morfini GA, Lee EB, Farah MH, Szodorai A, DeBoer SR et al (2005). Axonal transport, amyloid precursor protein, kinesin-1, and the processing apparatus: revisited. J Neurosci 25: 2386-2395.
83. Leblond CS, Heinrich J, Delorme R, Proepper C, Betancur C, Huguet G et al (2012). Genetic and functional analyses of SHANK2 mutations suggest a multiple hit model of autism spectrum disorders. PLoS Genet 8: e1002521.
84. Lennertz L, Wagner M, Wolwer W, Schuhmacher A, Frommann I, Berning J et al (2012). A promoter variant of SHANK1 affects auditory working memory in schizophrenia patients and in subjects clinically at risk for psychosis. Eur Arch Psychiatry Clin Neurosci 262: 117-124.
85. Lesch KP, Timmesfeld N, Renner TJ, Halperin R, Roser C, Nguyen TT et al (2008). Molecular genetics of adult ADHD: converging evidence from genome-wide association and extended pedigree linkage studies. J Neural Transm 115: 1573-1585.
86. Linhoff MW, Lauren J, Cassidy RM, Dobie FA, Takahashi H, Nygaard HB et al (2009). An unbiased expression screen for synaptogenic proteins identifies the LRRTM protein family as synaptic organizers. Neuron 61: 734-749.
87. Martin BS, Huntsman MM (2012). Pathological plasticity in fragile X syndrome. Neural Plast 2012: 275630.
88. Matsuda K, Miura E, Miyazaki T, Kakegawa W, Emi K, Narumi S et al (2010). Cbln1 is a ligand for an orphan glutamate receptor delta2, a bidirectional synapse organizer. Science 328: 363-368.
89. Maximov A, Bezprozvanny I (2002). Synaptic targeting of N-type calcium channels in hippocampal neurons. J Neurosci 22: 6939-6952.
90. Maximov A, Sudhof TC, Bezprozvanny I (1999). Association of neuronal calcium channels with modular adaptor proteins. J Biol Chem 274: 24453-24456.
91. McAllister AK (2007). Dynamic aspects of CNS synapse formation. Annu Rev Neurosci 30: 425-450.
92. McLennan Y, Polussa J, Tassone F, Hagerman R (2011). Fragile X syndrome. Curr Genomics 12: 216-224.
93. Missler M, Zhang W, Rohlmann A, Kattenstroth G, Hammer RE, Gottmann K et al (2003). Alpha-neurexins couple Ca2+ channels to synaptic vesicle exocytosis. Nature 423: 939-948.
94. Najm J, Horn D, Wimplinger I, Golden JA, Chizhikov VV, Sudi J et al (2008). Mutations of CASK cause an X-linked brain malformation phenotype with microcephaly and hypoplasia of the brainstem and cerebellum. Nat Genet 40: 1065-1067.
95. Nam CI, Chen L (2005). Postsynaptic assembly induced by neurexin-neuroligin interaction and neurotransmitter. Proc Natl Acad Sci USA 102: 6137-6142.
96. Napolioni V, Curatolo P (2008). Genetics and molecular biology of tuberous sclerosis complex. Curr Genomics 9: 475-487.
97. Nelson CD, Kim MJ, Hsin H, Chen Y, Sheng M (2013). Phosphorylation of threonine-19 of PSD-95 by GSK-3beta is required for PSD-95 mobilization and long-term depression. J Neurosci 33: 12122-12135.
98. Nguyen MV, Du F, Felice CA, Shan X, Nigam A, Mandel G et al (2012). MeCP2 is critical for maintaining mature neuronal networks and global brain anatomy during late stages of postnatal brain development and in the mature adult brain. J Neurosci 32: 10021-10034.
99. O'Dushlaine C, Kenny E, Heron E, Donohoe G, Gill M, Morris D et al (2011). Molecular pathways involved in neuronal cell adhesion and membrane scaffolding contribute to schizophrenia and bipolar disorder susceptibility. Mol Psychiatry 16: 286-292.
100. Park M, Watanabe S, Poon VY, Ou CY, Jorgensen EM, Shen K (2011). CYY-1/cyclin Y and CDK-5 differentially regulate synapse elimination and formation for rewiring neural circuits. Neuron 70: 742-757.
101. Peca J, Feliciano C, Ting JT, Wang W, Wells MF, Venkatraman TN et al (2011a). Shank3 mutant mice display autistic-like behaviours and striatal dysfunction. Nature 472: 437-442.
102. Peca J, Ting J, Feng G (2011b). SnapShot: autism and the synapse. Cell 147: 706, 706 e701.
103. Petralia RS, Sans N, Wang YX, Wenthold RJ (2005). Ontogeny of postsynaptic density proteins at glutamatergic synapses. Mol Cell Neurosci 29: 436-452.
104. Pfrieger FW, Barres BA (1997). Synaptic efficacy enhanced by glial cells in vitro. Science 277: 1684-1687.
105. Radyushkin K, Hammerschmidt K, Boretius S, Varoqueaux F, El-Kordi A, Ronnenberg A et al (2009). Neuroligin-3-deficient mice: model of a monogenic heritable form of autism with an olfactory deficit. Genes Brain Behav 8: 416-425.
106. Ramos-Miguel A, Meana JJ, Garcia-Sevilla JA (2012). Cyclin-dependent kinase-5 and p35/p25 activators in schizophrenia and major depression prefrontal cortex: basal contents and effects of psychotropic medications. Int J Neuropsychopharmacol 16: 683-689.
107. Reichelt AC, Rodgers RJ, Clapcote SJ (2012). The role of neurexins in schizophrenia and autistic spectrum disorder. Neuropharmacology 62: 1519-1526.
108. Robbins EM, Krupp AJ, Perez de Arce K, Ghosh AK, Fogel AI, Boucard A et al (2010). SynCAM 1 adhesion dynamically regulates synapse number and impacts plasticity and learning. Neuron 68: 894-906.
109. Rovelet-Lecrux A, Hannequin D, Guillin O, Legallic S, Jurici S, Wallon D et al (2012). Frontotemporal dementia phenotype associated with MAPT gene duplication. J Alzheimers Dis 21: 897-902.
110. Sabo SL, McAllister AK (2003). Mobility and cycling of synaptic protein-containing vesicles in axonal growth cone filopodia. Nat Neurosci 6: 1264-1269.
111. Sala C, Piech V, Wilson NR, Passafaro M, Liu G, Sheng M (2001). Regulation of dendritic spine morphology and synaptic function by Shank and Homer. Neuron 31: 115-130.
112. Salinas PC (2005). Retrograde signalling at the synapse: a role for Wnt proteins. Biochem Soc Trans 33: 1295-1298.
113. Samuels BA, Hsueh YP, Shu T, Liang H, Tseng HC, Hong CJ et al (2007). Cdk5 promotes synaptogenesis by regulating the subcellular distribution of the MAGUK family member CASK. Neuron 56: 823-837.
114. Sapir T, Frotscher M, Levy T, Mandelkow EM, Reiner O (2012). Tau's role in the developing brain: implications for intellectual disability. Hum Mol Genet 21: 1681-1692.
115. Sato D, Lionel AC, Leblond CS, Prasad A, Pinto D, Walker S et al (2012). SHANK1 deletions in males with autism spectrum disorder. Am J Hum Genet 90: 879-887.
116. Scheiffele P, Fan J, Choih J, Fetter R, Serafini T (2000). Neuroligin expressed in nonneuronal cells triggers presynaptic development in contacting axons. Cell 101: 657-669.
117. Setou M, Nakagawa T, Seog DH, Hirokawa N (2000). Kinesin superfamily motor protein KIF17 and mLin-10 in NMDA receptor-containing vesicle transport. Science 288: 1796-1802.
118. Setou M, Seog DH, Tanaka Y, Kanai Y, Takei Y, Kawagishi M et al (2002). Glutamate-receptor-interacting protein GRIP1 directly steers kinesin to dendrites. Nature 417: 83-87.
119. Shaw-Smith C, Pittman AM, Willatt L, Martin H, Rickman L, Gribble S et al (2006). Microdeletion encompassing MAPT at chromosome 17q21.3 is associated with developmental delay and learning disability. Nat Genet 38: 1032-1037.
120. Shipman SL, Schnell E, Hirai T, Chen BS, Roche KW, Nicoll RA (2012). Functional dependence of neuroligin on a new non-PDZ intracellular domain. Nat Neurosci 14: 718-726.
121. Siddiqui TJ, Pancaroglu R, Kang Y, Rooyakkers A, Craig AM (2010). LRRTMs and neuroligins bind neurexins with a differential code to cooperate in glutamate synapse development. J Neurosci 30: 7495-7506.
122. Silverman JL, Turner SM, Barkan CL, Tolu SS, Saxena R, Hung AY et al (2011). Sociability and motor functions in Shank1 mutant mice. Brain Res 1380: 120-137.
123. Smith DS, Tsai LH (2002). Cdk5 behind the wheel: a role in trafficking and transport? Trends Cell Biol 12: 28-36.
124. Soler-Llavina GJ, Fuccillo MV, Ko J, Sudhof TC, Malenka RC (2011). The neurexin ligands, neuroligins and leucine-rich repeat transmembrane proteins, perform convergent and divergent synaptic functions in vivo. Proc Natl Acad Sci USA 108: 16502-16509.
125. Song JY, Ichtchenko K, Sudhof TC, Brose N (1999). Neuroligin 1 is a postsynaptic cell-adhesion molecule of excitatory synapses. Proc Natl Acad Sci USA 96: 1100-1105.
126. Sons MS, Busche N, Strenzke N, Moser T, Ernsberger U, Mooren FC et al (2006). alpha-Neurexins are required for efficient transmitter release and synaptic homeostasis at the mouse neuromuscular junction. Neuroscience 138: 433-446.
127. Stagi M, Fogel AI, Biederer T (2010). SynCAM 1 participates in axo-dendritic contact assembly and shapes neuronal growth cones. Proc Natl Acad Sci USA 107: 7568-7573.
128. Sudhof TC (2008). Neuroligins and neurexins link synaptic function to cognitive disease. Nature 455: 903-911.
129. Szatmari P, Paterson AD, Zwaigenbaum L, Roberts W, Brian J, Liu XQ et al (2007). Mapping autism risk loci using genetic linkage and chromosomal rearrangements. Nat Genet 39: 319-328.
130. Tabuchi K, Blundell J, Etherton MR, Hammer RE, Liu X, Powell CM et al (2007). A neuroligin-3 mutation implicated in autism increases inhibitory synaptic transmission in mice. Science 318: 71-76.
131. Tabuchi K, Sudhof TC (2002). Structure and evolution of neurexin genes: insight into the mechanism of alternative splicing. Genomics 79: 849-859.
132. Takashima A, Yamaguchi H, Noguchi K, Michel G, Ishiguro K, Sato K et al (1995). Amyloid beta peptide induces cytoplasmic accumulation of amyloid protein precursor via tau protein kinase I/glycogen synthase kinase-3 beta in rat hippocampal neurons. Neurosci Lett 198: 83-86.
133. Tarabeux J, Champagne N, Brustein E, Hamdan FF, Gauthier J, Lapointe M et al (2010). De novo truncating mutation in Kinesin 17 associated with schizophrenia. Biol Psychiatry 68: 649-656.
134. Toro R, Konyukh M, Delorme R, Leblond C, Chaste P, Fauchereau F et al (2010). Key role for gene dosage and synaptic homeostasis in autism spectrum disorders. Trends Genet 26: 363-372.
135. Troca-Marin JA, Alves-Sampaio A, Montesinos ML (2012). Deregulated mTOR-mediated translation in intellectual disability. Prog Neurobiol 96: 268-282.
136. Tropepe V, Sive HL (2003). Can zebrafish be used as a model to study the neurodevelopmental causes of autism? Genes Brain Behav 2: 268-281.
137. Uemura T, Lee SJ, Yasumura M, Takeuchi T, Yoshida T, Ra M et al (2010). Transsynaptic interaction of GluRdelta2 and Neurexin through Cbln1 mediates synapse formation in the cerebellum. Cell 141: 1068-1079.
138. Varoqueaux F, Aramuni G, Rawson RL, Mohrmann R, Missler M, Gottmann K et al (2006). Neuroligins determine synapse maturation and function. Neuron 51: 741-754.
139. Venturin M, Moncini S, Villa V, Russo S, Bonati MT, Larizza L et al (2006). Mutations and novel polymorphisms in coding regions and UTRs of CDK5R1 and OMG genes in patients with non-syndromic mental retardation. Neurogenetics 7: 59-66.
140. Wang X, McCoy PA, Rodriguiz RM, Pan Y, Je HS, Roberts AC et al (2011). Synaptic dysfunction and abnormal behaviors in mice lacking major isoforms of Shank3. Hum Mol Genet 20: 3093-3108.
141. Washbourne P, Bennett JE, McAllister AK (2002). Rapid recruitment of NMDA receptor transport packets to nascent synapses. Nat Neurosci 5: 751-759.
142. Washbourne P, Dityatev A, Scheiffele P, Biederer T, Weiner JA, Christopherson KS et al (2004). Cell adhesion molecules in synapse formation. J Neurosci 24: 9244-9249.
143. Weinberger DR, Levitt P (2011). Neurodevelopmental origins of schizophrenia. In: Schizophrenia, 3rd edn, DR Weinberger, PJ Harrison (eds), Wiley-Blackwell Publishing: Oxford, UK, pp 393-412.
144. Witt J, Marks WJ Jr. (2011). An update on gene therapy in Parkinson's disease. Curr Neurol Neurosci Rep 11: 362-370.
145. Wohr M, Roullet FI, Hung AY, Sheng M, Crawley JN (2011). Communication impairments in mice lacking Shank1: reduced levels of ultrasonic vocalizations and scent marking behavior. PLoS One 6: e20631.
146. Won H, Lee HR, Gee HY, Mah W, Kim JI, Lee J et al (2012). Autistic-like social behaviour in Shank2-mutant mice improved by restoring NMDA receptor function. Nature 486: 261-265.
147. Wong RW, Setou M, Teng J, Takei Y, Hirokawa N (2002). Overexpression of motor protein KIF17 enhances spatial and working memory in transgenic mice. Proc Natl Acad Sci USA 99: 14500-14505.
148. Wright GJ, Washbourne P (2011). Neurexins, neuroligins and LRRTMs: synaptic adhesion getting fishy. J Neurochem 117: 765-778.
149. Yin X, Feng X, Takei Y, Hirokawa N (2012). Regulation of NMDA receptor transport: a KIF17-cargo binding/releasing underlies synaptic plasticity and memory in vivo. J Neurosci 32: 5486-5499.
150. Zhang C, Atasoy D, Arac D, Yang X, Fucillo MV, Robison AJ et al (2010). Neurexins physically and functionally interact with GABA(A) receptors. Neuron 66: 403-416.
151. Zhiling Y, Fujita E, Tanabe Y, Yamagata T, Momoi T, Momoi MY (2008). Mutations in the gene encoding CADM1 are associated with autism spectrum disorder. Biochem Biophys Res Commun 377: 926-929.
152. Zoghbi HY (2003). Postnatal neurodevelopmental disorders: meeting at the synapse? Science 302: 826-830.